Status:

COMPLETED

Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborating Sponsors:

National Center for Complementary and Integrative Health (NCCIH)

Conditions:

Colic

Gastrointestinal Tract Infections

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

Brief Summary

This study will evaluate the safety and tolerability of the probiotic Lactobacillus reuteri (LR) in healthy adult patients. Patients will be randomized to receive either LR or placebo orally each day ...

Detailed Description

Lactobacillus reuteri oil drops are a natural product containing Lactobacillus reuteri (LR), which has traditionally been used for the establishment and maintenance of a well-functioning gastro-intest...

Eligibility Criteria

Inclusion

  • Healthy Adults (18 - 60 years old)
  • No other recognized illness

Exclusion

  • Pregnancy or breastfeeding
  • Patient taking immunosuppressive medications, including oral corticosteroids
  • Positive result of HIV, Hepatitis B, and/or Hepatitis C test
  • Abnormal lab test results
  • Gastrointestinal related diseases and surgeries
  • Patients with an allergy to antibiotics
  • Presence of fever or a pre-existing adverse event monitored in the study
  • No more than two study participants in one household
  • Use of probiotics in the last 90 days
  • Diarrheal illness within the past 30 days
  • Recent or current use of oral antibiotics /anti-fungals(in the past 2 weeks)
  • Current use of oral laxatives
  • Chronic alcohol use or more than 1 drink per day
  • Subjects with implanted prosthetic devices including prosthetic heart valves
  • Known sensitivity to sunflower oil or products containing linolenic/oleic acids
  • Will require that subject not take any other probiotic-containing products, including yogurt supplemented with probiotics during the 6-month period

Key Trial Info

Start Date :

October 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2011

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00922727

Start Date

October 1 2009

End Date

July 1 2011

Last Update

January 25 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas Health Science Center at Houston

Houston, Texas, United States, 77030